Guardant Health
GH
#3559
Rank
NZ$4.98 B
Marketcap
$40.55
Share price
-1.18%
Change (1 day)
-12.26%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2023 (TTM): -$8.11

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -$7.94. In 2022 the company made an earnings per share (EPS) of -$10.34 a decrease over its 2021 EPS that were of -$6.47.

EPS history for Guardant Health from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$8.11-21.57%
2022-$10.3460%
2021-$6.4755.04%
2020-$4.17207.14%
2019-$1.36-19.81%
2018-$1.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$7.79-1.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.19-97.57%๐Ÿ‡บ๐Ÿ‡ธ USA